Pure Global

17-OH Progesterone (Maglumi 17-OH Progesterone ) - India CDSCO Medical Device Registration

17-OH Progesterone (Maglumi 17-OH Progesterone ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000124_d10c374d602093e57bcf98a448feffcb_76ee0ec0a9c1fe60c9a6a74c3e42bd16. This device is marketed under the brand name Maglumi Starter 1+2. The license holder is ANAND HEALTHCARE SERVICES, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
17-OH Progesterone (Maglumi 17-OH Progesterone )
UID: IMP/IVD/2023/000124_d10c374d602093e57bcf98a448feffcb_76ee0ec0a9c1fe60c9a6a74c3e42bd16

Brand Name

Maglumi Starter 1+2

Device Class

Class B

Approving Authority

CDSCO

Product Information

The kit is an in vitro chemiluminescence immunoassay for the quantitative determination of 17ฮฑ-OH Progesterone (Maglumi Starter 1+2) in human serum and plasma using the MAGLUMI series Fully-auto chemiluminescence immunoassay analyzer and Biolumi series Integrated System, and the assay is used for an aid in the diagnosis and treatment of various disorders of the adrenal glands or the ovaries

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing